Literature DB >> 33826107

Moyamoya disease with refractory hypertension associated with peripheral arterial stenosis in the renal parenchyma.

Yosuke Inaguma1, Hiroshi Kaito2, Makiko Yoshida3, Shigeo Hara4, Ryojiro Tanaka1.   

Abstract

Moyamoya disease (MMD) has long been known to be associated with hypertension. While renal artery stenosis (RAS) is considered one of the causes of hypertension with MMD, most hypertension causes remain unexplained. A boy with MMD was diagnosed with renovascular hypertension (RVH) due to left-sided RAS by angiography. Although nephrectomy on the affected side for unilateral RVH was performed, hypertension poorly improved. Histopathological examination of the resected specimens revealed that the vascular lumen not only of the renal artery but also of peripheral vessels in the renal parenchyma was narrowed. He developed end-stage renal disease caused by multiple wasp stings and received a kidney transplant from a living donor with his remaining right kidney resected. His hypertension improved dramatically just after the operation. In histopathological findings, the narrowed vascular lumen was also observed in the resected right renal parenchyma similar to that in the left kidney. In our case, these pathological findings were the same as those of major vessels previously reported in MMD patients. Immunohistochemical staining with anti-renin antibody on bilateral intrinsic kidneys was strongly revealed in the Juxtaglomerular apparatus. He has been normotensive with the minimum amount of amlodipine since transplantation and resection of his intrinsic right kidney. This is the first report to show the possibility that peripheral arterial stenosis in the renal parenchyma due to MMD would result in refractory hypertension. If MMD patients have hypertension of unknown origin without significant RAS, it should be considered that the etiology may be peripheral arterial stenosis in the renal parenchyma.
© 2021. Japanese Society of Nephrology.

Entities:  

Keywords:  Histological finding; Hypertension; Moyamoya disease; Peripheral arterial stenosis; Renal parenchyma

Mesh:

Year:  2021        PMID: 33826107      PMCID: PMC8494833          DOI: 10.1007/s13730-021-00594-x

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  20 in total

1.  Renal artery lesions in patients with moyamoya disease: angiographic findings.

Authors:  I Yamada; Y Himeno; Y Matsushima; H Shibuya
Journal:  Stroke       Date:  2000-03       Impact factor: 7.914

2.  Histological features of middle cerebral arteries from patients treated for Moyamoya disease.

Authors:  Yasushi Takagi; Ken-ichiro Kikuta; Kazuhiko Nozaki; Nobuo Hashimoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2007-01       Impact factor: 1.742

Review 3.  Moyamoya disease: current concepts and future perspectives.

Authors:  Satoshi Kuroda; Kiyohiro Houkin
Journal:  Lancet Neurol       Date:  2008-11       Impact factor: 44.182

4.  High prevalence of systemic hypertension in pediatric patients with moyamoya disease years after surgical treatment.

Authors:  Joongyub Lee; Seung-Ki Kim; Hee Gyung Kang; Il-Soo Ha; Kyu-Chang Wang; Ji Yeoun Lee; Ji Hoon Phi
Journal:  J Neurosurg Pediatr       Date:  2019-11-08       Impact factor: 2.375

5.  Moyamoya disease complicated with renal artery stenosis and nephrotic syndrome: reversal of nephrotic syndrome after nephrectomy.

Authors:  F Kuwayama; Y Hamasaki; T Shinagawa; C Kubota; I Ichikawa; Y Kato; S Oi; O Shinohara
Journal:  J Pediatr       Date:  2001-03       Impact factor: 4.406

6.  Pediatric renovascular hypertension: Treatment outcome according to underlying disease.

Authors:  Yeonhee Lee; Young Shin Lim; Sang Taek Lee; Heeyeon Cho
Journal:  Pediatr Int       Date:  2018-02-26       Impact factor: 1.524

7.  Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension.

Authors:  S Wallace; D-C Guo; E Regalado; L Mellor-Crummey; M Bamshad; D A Nickerson; R Dauser; N Hanchard; R Marom; E Martin; V Berka; I Sharina; V Ganesan; D Saunders; S A Morris; D M Milewicz
Journal:  Clin Genet       Date:  2016-02-18       Impact factor: 4.438

Review 8.  Human hypertension, sympathetic activity and the selfish brain.

Authors:  Emma C Hart
Journal:  Exp Physiol       Date:  2016-12-01       Impact factor: 2.969

Review 9.  The Pathophysiology of Moyamoya Disease: An Update.

Authors:  Oh Young Bang; Miki Fujimura; Seung-Ki Kim
Journal:  J Stroke       Date:  2016-01-29       Impact factor: 6.967

10.  Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo.

Authors:  Hatasu Kobayashi; Yoshiko Matsuda; Toshiaki Hitomi; Hiroko Okuda; Hirotomo Shioi; Tetsuya Matsuda; Hirohiko Imai; Masakatsu Sone; Daisuke Taura; Kouji H Harada; Toshiyuki Habu; Yasushi Takagi; Susumu Miyamoto; Akio Koizumi
Journal:  J Am Heart Assoc       Date:  2015-06-30       Impact factor: 5.501

View more
  2 in total

Review 1.  Research progress of moyamoya disease combined with renovascular hypertension.

Authors:  Erheng Liu; Heng Zhao; Chengyuan Liu; Xueyi Tan; Chao Luo; Shuaifeng Yang
Journal:  Front Surg       Date:  2022-08-26

2.  Multislice Computed Tomography Angiography Imaging Diagnosis of Lower Extremity Arteriosclerosis in Patients with Hypertension and Its Correlation with the Level of High-Sensitivity C-Reactive Protein.

Authors:  Jing Huo; Zhongyin Wu; Haijun Jiang; Hong Zhang
Journal:  Comput Math Methods Med       Date:  2022-08-31       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.